Case Report: Kanamycin Ototoxicity and MDR-TB Treatment Regimen
Bahru Mantefardo,1 Gizaw Sisay2 1Department of Internal Medicine, School of Medicine, College of Medicine and Health Sciences, Dilla University, Dilla, Ethiopia; 2School of Public Health, College of Medicine and Health Sciences, Dilla University, Dilla, EthiopiaCorrespondence: Gizaw Sisay Tel +25191...
Guardado en:
Autores principales: | Mantefardo B, Sisay G |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ace0f7f7de024dfda1bd22822cbdae6a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identificación molecular de enzimas modificantes de aminoglucósidos en cepas de Enterococcus spp. aisladas en hospitales de la Octava Región de Chile
por: Sepúlveda A,Marcela, et al.
Publicado: (2007) -
Nicotine induced ototoxicity in rat cochlear organotypic cultures
por: Zhao Yi, et al.
Publicado: (2021) -
Prevalence and Manifestation of Ototoxic Medications Among the Adult Attendees of The Audiovestibular unit at Al-Zahraa University Hospital, Cairo, Egypt
por: Iman Eladawy, et al.
Publicado: (2020) -
Community-Based Ototoxicity Monitoring for Drug-Resistant Tuberculosis in South Africa: An Evaluation Study
por: Lucia Jane Stevenson, et al.
Publicado: (2021) -
A Dual Marker for Monitoring MDR-TB Treatment: Host-Derived miRNAs and M. tuberculosis-Derived RNA Sequences in Serum
por: Claudia Carranza, et al.
Publicado: (2021)